SEC Form 4 · accession 0000899243-15-009344
Baxalta Inc · BXLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacopo Leonardi
Officer — EVP and President, Immunology
Period of report
Dec 3, 2015
Accepted (ET)
Dec 4, 2015 · 8:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per shareF1 | Dec 3, 2015 | F | 835 | $34.98 | D | 27,505 | D | |
| Common Stock, par value $0.01 per share | holding | — | — | — | 1,094 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock granted on December 3, 2012.